aluates Reports

$ 0.0

Automative

Global Personalizing Cancer Drugs Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-26D6003

Global Personalizing Cancer Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Personalizing Cancer Drugs Market Research Report 2024

Code: QYRE-Auto-26D6003

Report

February 2024

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

GlaxoSmithKline PLC

Novartis

Sanofi

Pfizer Inc

Amgen Inc

Merck

Bristol–Myers Squibb

Celgene Corporation

Ariad Pharmaceuticals

Eli Lilly

Hoffmann La Roche

Boehringer Ingelheim

Johnson and Johnson

Teva Pharmaceuticals

Personalizing Cancer Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Personalizing Cancer Drugs Market

The global Personalizing Cancer Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Personalizing Cancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalizing Cancer Drugs.

Report Scope

The Personalizing Cancer Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Personalizing Cancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Personalizing Cancer Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Personalizing Cancer Drugs Market Report

Report Metric	Details
Report Name	Personalizing Cancer Drugs Market
CAGR	5%
Segment by Type	Immunotherapy Targeted Therapy Chemotherapy Hormone Therapy Others
Segment by Application	Breast Cancer Blood Cancer Gastrointestinal Cancer Prostate Cancer Skin Cancer Lung Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, GlaxoSmithKline, Novartis, Sanofi, Pfizer, Amgen, Merck, Bristol-Myers Squibb, Celgene Corporation, Ariad Pharmaceuticals, Eli Lilly, Hoffmann-La Roche, Boehringer Ingelheim, Johnson and Johnson, Teva Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalizing Cancer Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Personalizing Cancer Drugs Market report?

Ans: The main players in the Personalizing Cancer Drugs Market are Bayer, GlaxoSmithKline, Novartis, Sanofi, Pfizer, Amgen, Merck, Bristol-Myers Squibb, Celgene Corporation, Ariad Pharmaceuticals, Eli Lilly, Hoffmann-La Roche, Boehringer Ingelheim, Johnson and Johnson, Teva Pharmaceuticals

What are the Application segmentation covered in the Personalizing Cancer Drugs Market report?

Ans: The Applications covered in the Personalizing Cancer Drugs Market report are Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer, Others

What are the Type segmentation covered in the Personalizing Cancer Drugs Market report?

Ans: The Types covered in the Personalizing Cancer Drugs Market report are Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Personalizing Cancer Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Immunotherapy

1.2.3 Targeted Therapy

1.2.4 Chemotherapy

1.2.5 Hormone Therapy

1.2.6 Others

1.3 Market by Application

1.3.1 Global Personalizing Cancer Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Breast Cancer

1.3.3 Blood Cancer

1.3.4 Gastrointestinal Cancer

1.3.5 Prostate Cancer

1.3.6 Skin Cancer

1.3.7 Lung Cancer

1.3.8 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Personalizing Cancer Drugs Market Perspective (2019-2030)

2.2 Personalizing Cancer Drugs Growth Trends by Region

2.2.1 Global Personalizing Cancer Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Personalizing Cancer Drugs Historic Market Size by Region (2019-2024)

2.2.3 Personalizing Cancer Drugs Forecasted Market Size by Region (2025-2030)

2.3 Personalizing Cancer Drugs Market Dynamics

2.3.1 Personalizing Cancer Drugs Industry Trends

2.3.2 Personalizing Cancer Drugs Market Drivers

2.3.3 Personalizing Cancer Drugs Market Challenges

2.3.4 Personalizing Cancer Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Personalizing Cancer Drugs Players by Revenue

3.1.1 Global Top Personalizing Cancer Drugs Players by Revenue (2019-2024)

3.1.2 Global Personalizing Cancer Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Personalizing Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Personalizing Cancer Drugs Revenue

3.4 Global Personalizing Cancer Drugs Market Concentration Ratio

3.4.1 Global Personalizing Cancer Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Personalizing Cancer Drugs Revenue in 2023

3.5 Personalizing Cancer Drugs Key Players Head office and Area Served

3.6 Key Players Personalizing Cancer Drugs Product Solution and Service

3.7 Date of Enter into Personalizing Cancer Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Personalizing Cancer Drugs Breakdown Data by Type

4.1 Global Personalizing Cancer Drugs Historic Market Size by Type (2019-2024)

4.2 Global Personalizing Cancer Drugs Forecasted Market Size by Type (2025-2030)

5 Personalizing Cancer Drugs Breakdown Data by Application

5.1 Global Personalizing Cancer Drugs Historic Market Size by Application (2019-2024)

5.2 Global Personalizing Cancer Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Personalizing Cancer Drugs Market Size (2019-2030)

6.2 North America Personalizing Cancer Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Personalizing Cancer Drugs Market Size by Country (2019-2024)

6.4 North America Personalizing Cancer Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Personalizing Cancer Drugs Market Size (2019-2030)

7.2 Europe Personalizing Cancer Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Personalizing Cancer Drugs Market Size by Country (2019-2024)

7.4 Europe Personalizing Cancer Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Personalizing Cancer Drugs Market Size (2019-2030)

8.2 Asia-Pacific Personalizing Cancer Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Personalizing Cancer Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Personalizing Cancer Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Personalizing Cancer Drugs Market Size (2019-2030)

9.2 Latin America Personalizing Cancer Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Personalizing Cancer Drugs Market Size by Country (2019-2024)

9.4 Latin America Personalizing Cancer Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Personalizing Cancer Drugs Market Size (2019-2030)

10.2 Middle East & Africa Personalizing Cancer Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Personalizing Cancer Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Personalizing Cancer Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Detail

11.1.2 Bayer Business Overview

11.1.3 Bayer Personalizing Cancer Drugs Introduction

11.1.4 Bayer Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.1.5 Bayer Recent Development

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Detail

11.2.2 GlaxoSmithKline Business Overview

11.2.3 GlaxoSmithKline Personalizing Cancer Drugs Introduction

11.2.4 GlaxoSmithKline Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.2.5 GlaxoSmithKline Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Personalizing Cancer Drugs Introduction

11.3.4 Novartis Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Detail

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Personalizing Cancer Drugs Introduction

11.4.4 Sanofi Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.4.5 Sanofi Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Detail

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Personalizing Cancer Drugs Introduction

11.5.4 Pfizer Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.5.5 Pfizer Recent Development

11.6 Amgen

11.6.1 Amgen Company Detail

11.6.2 Amgen Business Overview

11.6.3 Amgen Personalizing Cancer Drugs Introduction

11.6.4 Amgen Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.6.5 Amgen Recent Development

11.7 Merck

11.7.1 Merck Company Detail

11.7.2 Merck Business Overview

11.7.3 Merck Personalizing Cancer Drugs Introduction

11.7.4 Merck Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.7.5 Merck Recent Development

11.8 Bristol-Myers Squibb

11.8.1 Bristol-Myers Squibb Company Detail

11.8.2 Bristol-Myers Squibb Business Overview

11.8.3 Bristol-Myers Squibb Personalizing Cancer Drugs Introduction

11.8.4 Bristol-Myers Squibb Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.8.5 Bristol-Myers Squibb Recent Development

11.9 Celgene Corporation

11.9.1 Celgene Corporation Company Detail

11.9.2 Celgene Corporation Business Overview

11.9.3 Celgene Corporation Personalizing Cancer Drugs Introduction

11.9.4 Celgene Corporation Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.9.5 Celgene Corporation Recent Development

11.10 Ariad Pharmaceuticals

11.10.1 Ariad Pharmaceuticals Company Detail

11.10.2 Ariad Pharmaceuticals Business Overview

11.10.3 Ariad Pharmaceuticals Personalizing Cancer Drugs Introduction

11.10.4 Ariad Pharmaceuticals Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.10.5 Ariad Pharmaceuticals Recent Development

11.11 Eli Lilly

11.11.1 Eli Lilly Company Detail

11.11.2 Eli Lilly Business Overview

11.11.3 Eli Lilly Personalizing Cancer Drugs Introduction

11.11.4 Eli Lilly Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.11.5 Eli Lilly Recent Development

11.12 Hoffmann-La Roche

11.12.1 Hoffmann-La Roche Company Detail

11.12.2 Hoffmann-La Roche Business Overview

11.12.3 Hoffmann-La Roche Personalizing Cancer Drugs Introduction

11.12.4 Hoffmann-La Roche Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.12.5 Hoffmann-La Roche Recent Development

11.13 Boehringer Ingelheim

11.13.1 Boehringer Ingelheim Company Detail

11.13.2 Boehringer Ingelheim Business Overview

11.13.3 Boehringer Ingelheim Personalizing Cancer Drugs Introduction

11.13.4 Boehringer Ingelheim Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.13.5 Boehringer Ingelheim Recent Development

11.14 Johnson and Johnson

11.14.1 Johnson and Johnson Company Detail

11.14.2 Johnson and Johnson Business Overview

11.14.3 Johnson and Johnson Personalizing Cancer Drugs Introduction

11.14.4 Johnson and Johnson Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.14.5 Johnson and Johnson Recent Development

11.15 Teva Pharmaceuticals

11.15.1 Teva Pharmaceuticals Company Detail

11.15.2 Teva Pharmaceuticals Business Overview

11.15.3 Teva Pharmaceuticals Personalizing Cancer Drugs Introduction

11.15.4 Teva Pharmaceuticals Revenue in Personalizing Cancer Drugs Business (2019-2024)

11.15.5 Teva Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bayer

GlaxoSmithKline PLC

Novartis

Sanofi

Pfizer Inc

Amgen Inc

Merck

Bristol–Myers Squibb

Celgene Corporation

Ariad Pharmaceuticals

Eli Lilly

Hoffmann La Roche

Boehringer Ingelheim

Johnson and Johnson

Teva Pharmaceuticals

List of Tables

Table 1. Global Personalizing Cancer Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Immunotherapy

Table 3. Key Players of Targeted Therapy

Table 4. Key Players of Chemotherapy

Table 5. Key Players of Hormone Therapy

Table 6. Key Players of Others

Table 7. Global Personalizing Cancer Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Personalizing Cancer Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Personalizing Cancer Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Personalizing Cancer Drugs Market Share by Region (2019-2024)

Table 11. Global Personalizing Cancer Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Personalizing Cancer Drugs Market Share by Region (2025-2030)

Table 13. Personalizing Cancer Drugs Market Trends

Table 14. Personalizing Cancer Drugs Market Drivers

Table 15. Personalizing Cancer Drugs Market Challenges

Table 16. Personalizing Cancer Drugs Market Restraints

Table 17. Global Personalizing Cancer Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Personalizing Cancer Drugs Market Share by Players (2019-2024)

Table 19. Global Top Personalizing Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalizing Cancer Drugs as of 2023)

Table 20. Ranking of Global Top Personalizing Cancer Drugs Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Personalizing Cancer Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Personalizing Cancer Drugs Product Solution and Service

Table 24. Date of Enter into Personalizing Cancer Drugs Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Personalizing Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Personalizing Cancer Drugs Revenue Market Share by Type (2019-2024)

Table 28. Global Personalizing Cancer Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Personalizing Cancer Drugs Revenue Market Share by Type (2025-2030)

Table 30. Global Personalizing Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Personalizing Cancer Drugs Revenue Market Share by Application (2019-2024)

Table 32. Global Personalizing Cancer Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Personalizing Cancer Drugs Revenue Market Share by Application (2025-2030)

Table 34. North America Personalizing Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Personalizing Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Personalizing Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Personalizing Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Personalizing Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Personalizing Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Personalizing Cancer Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Personalizing Cancer Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Personalizing Cancer Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Personalizing Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Personalizing Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Personalizing Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Personalizing Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Personalizing Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Personalizing Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 49. Bayer Company Detail

Table 50. Bayer Business Overview

Table 51. Bayer Personalizing Cancer Drugs Product

Table 52. Bayer Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 53. Bayer Recent Development

Table 54. GlaxoSmithKline Company Detail

Table 55. GlaxoSmithKline Business Overview

Table 56. GlaxoSmithKline Personalizing Cancer Drugs Product

Table 57. GlaxoSmithKline Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 58. GlaxoSmithKline Recent Development

Table 59. Novartis Company Detail

Table 60. Novartis Business Overview

Table 61. Novartis Personalizing Cancer Drugs Product

Table 62. Novartis Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 63. Novartis Recent Development

Table 64. Sanofi Company Detail

Table 65. Sanofi Business Overview

Table 66. Sanofi Personalizing Cancer Drugs Product

Table 67. Sanofi Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 68. Sanofi Recent Development

Table 69. Pfizer Company Detail

Table 70. Pfizer Business Overview

Table 71. Pfizer Personalizing Cancer Drugs Product

Table 72. Pfizer Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 73. Pfizer Recent Development

Table 74. Amgen Company Detail

Table 75. Amgen Business Overview

Table 76. Amgen Personalizing Cancer Drugs Product

Table 77. Amgen Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 78. Amgen Recent Development

Table 79. Merck Company Detail

Table 80. Merck Business Overview

Table 81. Merck Personalizing Cancer Drugs Product

Table 82. Merck Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 83. Merck Recent Development

Table 84. Bristol-Myers Squibb Company Detail

Table 85. Bristol-Myers Squibb Business Overview

Table 86. Bristol-Myers Squibb Personalizing Cancer Drugs Product

Table 87. Bristol-Myers Squibb Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 88. Bristol-Myers Squibb Recent Development

Table 89. Celgene Corporation Company Detail

Table 90. Celgene Corporation Business Overview

Table 91. Celgene Corporation Personalizing Cancer Drugs Product

Table 92. Celgene Corporation Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 93. Celgene Corporation Recent Development

Table 94. Ariad Pharmaceuticals Company Detail

Table 95. Ariad Pharmaceuticals Business Overview

Table 96. Ariad Pharmaceuticals Personalizing Cancer Drugs Product

Table 97. Ariad Pharmaceuticals Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 98. Ariad Pharmaceuticals Recent Development

Table 99. Eli Lilly Company Detail

Table 100. Eli Lilly Business Overview

Table 101. Eli Lilly Personalizing Cancer Drugs Product

Table 102. Eli Lilly Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 103. Eli Lilly Recent Development

Table 104. Hoffmann-La Roche Company Detail

Table 105. Hoffmann-La Roche Business Overview

Table 106. Hoffmann-La Roche Personalizing Cancer Drugs Product

Table 107. Hoffmann-La Roche Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 108. Hoffmann-La Roche Recent Development

Table 109. Boehringer Ingelheim Company Detail

Table 110. Boehringer Ingelheim Business Overview

Table 111. Boehringer Ingelheim Personalizing Cancer Drugs Product

Table 112. Boehringer Ingelheim Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 113. Boehringer Ingelheim Recent Development

Table 114. Johnson and Johnson Company Detail

Table 115. Johnson and Johnson Business Overview

Table 116. Johnson and Johnson Personalizing Cancer Drugs Product

Table 117. Johnson and Johnson Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 118. Johnson and Johnson Recent Development

Table 119. Teva Pharmaceuticals Company Detail

Table 120. Teva Pharmaceuticals Business Overview

Table 121. Teva Pharmaceuticals Personalizing Cancer Drugs Product

Table 122. Teva Pharmaceuticals Revenue in Personalizing Cancer Drugs Business (2019-2024) & (US$ Million)

Table 123. Teva Pharmaceuticals Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Personalizing Cancer Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Personalizing Cancer Drugs Market Share by Type: 2023 VS 2030

Figure 3. Immunotherapy Features

Figure 4. Targeted Therapy Features

Figure 5. Chemotherapy Features

Figure 6. Hormone Therapy Features

Figure 7. Others Features

Figure 8. Global Personalizing Cancer Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Personalizing Cancer Drugs Market Share by Application: 2023 VS 2030

Figure 10. Breast Cancer Case Studies

Figure 11. Blood Cancer Case Studies

Figure 12. Gastrointestinal Cancer Case Studies

Figure 13. Prostate Cancer Case Studies

Figure 14. Skin Cancer Case Studies

Figure 15. Lung Cancer Case Studies

Figure 16. Others Case Studies

Figure 17. Personalizing Cancer Drugs Report Years Considered

Figure 18. Global Personalizing Cancer Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 19. Global Personalizing Cancer Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Personalizing Cancer Drugs Market Share by Region: 2023 VS 2030

Figure 21. Global Personalizing Cancer Drugs Market Share by Players in 2023

Figure 22. Global Top Personalizing Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalizing Cancer Drugs as of 2023)

Figure 23. The Top 10 and 5 Players Market Share by Personalizing Cancer Drugs Revenue in 2023

Figure 24. North America Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. North America Personalizing Cancer Drugs Market Share by Country (2019-2030)

Figure 26. United States Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Personalizing Cancer Drugs Market Share by Country (2019-2030)

Figure 30. Germany Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia-Pacific Personalizing Cancer Drugs Market Share by Region (2019-2030)

Figure 38. China Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Japan Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. India Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Australia Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Latin America Personalizing Cancer Drugs Market Share by Country (2019-2030)

Figure 46. Mexico Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Brazil Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Personalizing Cancer Drugs Market Share by Country (2019-2030)

Figure 50. Turkey Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Personalizing Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Bayer Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 53. GlaxoSmithKline Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 54. Novartis Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 55. Sanofi Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 56. Pfizer Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 57. Amgen Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 58. Merck Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 60. Celgene Corporation Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 61. Ariad Pharmaceuticals Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 62. Eli Lilly Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 63. Hoffmann-La Roche Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 64. Boehringer Ingelheim Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 65. Johnson and Johnson Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 66. Teva Pharmaceuticals Revenue Growth Rate in Personalizing Cancer Drugs Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions